Results 201 to 210 of about 761,768 (392)

Late‐Onset Spondyloarthritis Presenting as Glucocorticoid‐Resistant Polymyalgia Rheumatica: A Hitherto Underappreciated Entity in Which Tumor Necrosis Factor or Interleukin ‐17 Blockade May Have a Therapeutic Role

open access: yesArthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is an age‐related inflammatory disease with shoulder/hip girdle involvement. Magnetic resonance imaging (MRI) reveals extracapsular/entheseal soft tissue involvement in both PMR and spondyloarthritis (SpA), with sacroiliac joint and perientheseal spinal bone marrow edema (BME) being characteristic of SpA ...
Kerem Abacar   +12 more
wiley   +1 more source

PS118. Regional Differences in Patient Selection and Treatment of Carotid Artery Disease in the Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) [PDF]

open access: bronze, 2014
John C. McCallum   +7 more
openalex   +1 more source

King Aorta: Narrative anatomy education

open access: yesAnatomical Sciences Education, Volume 18, Issue 3, Page 264-276, March 2025.
Abstract The aim of this study was to investigate the effects of narrative anatomy education and traditional anatomy education on academic achievement. The study included 64 students who were randomly divided into two groups. The two groups were (n = 32) control (Group 1) and (n = 32) experimental (Group 2). The pretest scores of the two groups were 36.
Halil Yilmaz
wiley   +1 more source

Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease. [PDF]

open access: yesStroke Vasc Neurol, 2022
Nardi V   +8 more
europepmc   +1 more source

The Natural History of Common Carotid Artery Occlusive Disease [PDF]

open access: bronze, 2020
Abdul Q. Alarhayem   +7 more
openalex   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence for regulatory science and innovation in pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

Monocyte/Lymphocyte Ratio and MCHC as Predictors of Collateral Carotid Artery Disease-Preliminary Report. [PDF]

open access: yesJ Pers Med, 2021
Urbanowicz T   +7 more
europepmc   +1 more source

Transforming Brain Health With Neurotechnology Convergence (Part II): Intelligent Neurointervention Systems for Neurological Disorders

open access: yesBrain Health, EarlyView.
ABSTRACT Neurological disorders represent a critical domain within global health, necessitating advanced interventions to address complex pathologies such as tumors, functional disorders, and cerebrovascular diseases. Despite the proven benefits of early intervention, current treatment paradigms face significant challenges: (1) limited precision in ...
Qing Ye   +14 more
wiley   +1 more source

Carotid Artery Disease Among Broadly Defined Underrepresented Groups: The All of Us Research Program. [PDF]

open access: yesStroke, 2022
Renedo D   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy